4,184
Views
39
CrossRef citations to date
0
Altmetric
Coronaviruses

Experimental re-infected cats do not transmit SARS-CoV-2

, , , , , , , , , , ORCID Icon, , , , , ORCID Icon, , & ORCID Icon show all
Pages 638-650 | Received 18 Jan 2021, Accepted 10 Mar 2021, Published online: 02 Apr 2021

References

  • Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273.
  • Segales J, Puig M, Rodon J, et al. Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain. Proc Natl Acad Sci U S A. 2020;117(40):24790–24793.
  • Neira V, Brito B, Agüero B, et al. A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners. Emerg Microbes Infect. 2020;10:1–22.
  • Hosie MJ, Epifano I, Herder V, et al. Respiratory disease in cats associated with human-to-cat transmission of SARS-CoV-2 in the UK. bioRxiv. 2020;2020.09.23.309948.
  • Ruiz-Arrondo I, Portillo A, Palomar AM, et al. Detection of SARS-CoV-2 in pets living with COVID-19 owners diagnosed during the COVID-19 lockdown in Spain: a case of an asymptomatic cat with SARS-CoV-2 in Europe. Transbound Emerg Dis. 2020;00:1–4.
  • Sit THC, Brackman CJ, Ip SM, et al. Infection of dogs with SARS-CoV-2. Nature. 2020;586(7831):776–778.
  • Fritz M, Rosolen B, Krafft E, et al. High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households. One Health. 2021;11:100192.
  • Oreshkova N, Molenaar RJ, Vreman S, et al. SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020. Eurosurveillance. 2020 Jun;25(23):2001005. doi: https://doi.org/10.2807/1560-7917.ES.2020.25.23.2001005. PMID: 32553059; PMCID: PMC7403642.
  • Hammer AS, Quaade ML, Rasmussen TB, et al. SARS-CoV-2 transmission between mink (neovison vison) and humans, Denmark. Emerg Infect Dis. 2020;27(2) 547–551.
  • Oude Munnink BB, Sikkema RS, Nieuwenhuijse DF, et al. Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science. 2021;371(6525):172–177. doi: https://doi.org/10.1126/science.abe5901. Epub 2020 Nov 10. PMID: 33172935; PMCID: PMC7857398.
  • McNamara T, Richt JA, Glickman L. A critical needs assessment for research in companion animals and livestock following the pandemic of COVID-19 in humans. Vector Borne Zoonotic Dis. 2020;20(6):393–405.
  • Gaudreault NN, Trujillo JD, Carossino M, et al. SARS-CoV-2 infection, disease and transmission in domestic cats. Emerg Microbes Infect. 2020;9(1):2322–2332.
  • Shi J, Wen Z, Zhong G, et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020;368(6494):1016–1020.
  • Halfmann PJ, Hatta M, Chiba S, et al. Transmission of SARS-CoV-2 in domestic cats. N Engl J Med. 2020;383(6):592–594.
  • Bosco-Lauth AM, Hartwig AE, Porter SM, et al. Experimental infection of domestic dogs and cats with SARS-CoV-2: pathogenesis, transmission, and response to reexposure in cats. Proc Natl Acad Sci U S A. 2020;117(42):26382–26388.
  • Zhang Q, Zhang H, Gao J, et al. A serological survey of SARS-CoV-2 in cat in Wuhan. Emerg Microbes Infect. 2020;9(1):2013–2019.
  • Stevanovic V, Vilibic-Cavlek T, Tabain I, et al. Seroprevalence of SARS-CoV-2 infection among pet animals in Croatia and potential public health impact. Transbound Emerg Dis. 2020 Nov 15: doi: https://doi.org/10.1111/tbed.13924. Epub ahead of print. PMID: 33191649; PMCID: PMC7753394.
  • Lu X, Wang L, Sakthivel SK, et al. US CDC real-time reverse transcription PCR panel for detection of severe acute respiratory Syndrome coronavirus 2. Emerg Infect Dis. 2020;26(8):1654–1665.
  • Carossino M, Ip HS, Richt JA, et al. Detection of SARS-CoV-2 by RNAscope® in situ hybridization and immunohistochemistry techniques. Arch Virol. 2020;165(10):2373–2377.
  • Goldman JD, Wang K, Roltgen K, et al. Reinfection with SARS-CoV-2 and failure of humoral immunity: a case report. medRxiv [Preprint]. 2020 Sep 25:2020.09.22.20192443. doi: https://doi.org/10.1101/2020.09.22.20192443. PMID: 32995830; PMCID: PMC7523175.
  • To KK, Hung IF, Ip JD, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin Infect Dis. 2020 Aug 25. pii: 5897019. doi: https://doi.org/10.1093/cid/ciaa1275.
  • Tillett RL, Sevinsky JR, Hartley PD, et al. Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. 2020;21:52–58.
  • Van Elslande J, Vermeersch P, Vandervoort K, et al. Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain. Clin Infect Dis. 2020 Sep 5. pii: 5901661. doi: https://doi.org/10.1093/cid/ciaa1330.
  • Prado-Vivar B, Becerra-Wong M, Guadalupe JJ, et al. A case of SARS-CoV-2 reinfection in Ecuador. Lancet Infect Dis. 2020 Nov 23. pii: S1473-3099(20)30910-5. doi: https://doi.org/10.1016/S1473-3099(20)30910-5.
  • Gupta V, Bhoyar RC, Jain A, et al. Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2. Clin Infect Dis. 2020;Sep 23:ciaa1451. doi: https://doi.org/10.1093/cid/ciaa1451. Epub ahead of print. PMID: 32964927; PMCID: PMC7543380.
  • Gidari A, Nofri M, Saccarelli L, et al. Is recurrence possible in coronavirus disease 2019 (COVID-19)? case series and systematic review of literature. Eur J Clin Microbiol Infect Dis. 2020 Oct 10:1–12. doi: https://doi.org/10.1007/s10096-020-04057-6.
  • Cameron MJ, Kelvin AA, Leon AJ, et al. Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model. PLoS One. 2012;7(9):e45842. doi: https://doi.org/10.1371/journal.pone.0045842. Epub 2012 Sep 24.
  • Chandrashekar A, Liu J, Martinot AJ, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;369(6505):812–817.
  • Deng W, Bao L, Liu J, et al. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020;369(6505):818–823.
  • Liu W, Fontanet A, Zhang PH, et al. Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. J Infect Dis. 2006;193(6):792–795.
  • Mo H, Zeng G, Ren X, et al. Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology. 2006;11(1):49–53.
  • Wu LP, Wang NC, Chang YH, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13(10):1562–1564.
  • Cao WC, Liu W, Zhang PH, et al. Disappearance of antibodies to SARS-associated coronavirus after recovery. N Engl J Med. 2007;357(11):1162–1163.
  • Tang F, Quan Y, Xin ZT, et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J Immunol. 2011;186(12):7264–7268.
  • Choe PG, Perera R, Park WB, et al. MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015. Emerg Infect Dis. 2017;23(7):1079–1084.
  • Payne DC, Iblan I, Rha B, et al. Persistence of antibodies against Middle East Respiratory Syndrome coronavirus. Emerg Infect Dis. 2016;22(10):1824–1826.
  • Ali MA, Shehata MM, Gomaa MR, et al. Systematic, active surveillance for Middle East Respiratory Syndrome coronavirus in camels in Egypt. Emerg Microbes Infect. 2017;6(1):1–7.
  • Hemida MG, Alnaeem A, Chu DK, et al. Longitudinal study of Middle East Respiratory Syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014-2015. Emerg Microbes Infect. 2017;6(6):e56.
  • Edridge AWD, Kaczorowska J, Hoste ACR, et al. Seasonal coronavirus protective immunity is short-lasting. Nat Med. 2020;26(11):1691–1693.